Skip to content
Updates in Prostate Cancer: Combination Therapy Becoming the Best Approach?
Updates in Colorectal Cancer
Updates in Cholangiocarcinoma and Pancreas Cancer: What is new in Targeted Therapy or Immunotherapy?
Updates in Kidney and Bladder Cancers: Where we are with Immunotherapy and Precision Medicine?
Gynecologic Malignancies: New Targeted Therapy-IO-Chemo Combinations
Developments in Head and Neck Cancers Including Thyroid Malignancies
Novel Frontiers in the Use of ctDNA in Oncology
Breast Cancer Update in Hormone Sensitive Breast Cancer
New Developments in Metastatic Breast Cancer: Immunotherapy and Novel Therapeutic Pathways
New Developments in EGFR and K-RAS Therapies in NSCLC
Updates on Targeting ALK, ROS1 ,and RET in NSCLC
Most Relevant Data on Immunotherapy in Neo-Adjuvant, Adjuvant, and Metastatic NSCLC
The Era of Antibody Drug Conjugates in NSCLC Targeting Her-2, CEACAM5, TROP-2, and MET
Most Relevant News in Multiple Myeloma in 2023
Modern Challenges and New Options for B-cell NHL
Update on T-Cell Lymphomas
Lung Cancer Screening / Tobacco Control
Pulmonary – From Diagnostics to Therapeutics
Surgery for Early-Stage NSCLC
Adjuvant / Neo-adjuvant Systemic Therapy
Radiation in Early-Stage NSCLC
Locally Advanced NSCLC- Radiation Therapy
Stage III NSCLC– Surgical/ Combined Modality
Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy
Post navigation
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok 
